AnaptysBio Inc (ANAB)
21.42
+0.25
(+1.18%)
USD |
NASDAQ |
Nov 22, 11:23
AnaptysBio Max Drawdown (5Y): 92.08% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 92.08% |
| September 30, 2024 | 92.08% |
| August 31, 2024 | 92.08% |
| July 31, 2024 | 92.08% |
| June 30, 2024 | 92.08% |
| May 31, 2024 | 92.08% |
| April 30, 2024 | 92.08% |
| March 31, 2024 | 92.08% |
| February 29, 2024 | 92.08% |
| January 31, 2024 | 92.08% |
| December 31, 2023 | 92.08% |
| November 30, 2023 | 92.08% |
| October 31, 2023 | 92.08% |
| September 30, 2023 | 92.08% |
| August 31, 2023 | 92.08% |
| July 31, 2023 | 92.08% |
| June 30, 2023 | 92.08% |
| May 31, 2023 | 92.08% |
| April 30, 2023 | 92.08% |
| March 31, 2023 | 92.08% |
| February 28, 2023 | 92.08% |
| January 31, 2023 | 92.08% |
| December 31, 2022 | 92.08% |
| November 30, 2022 | 92.08% |
| October 31, 2022 | 92.08% |
| Date | Value |
|---|---|
| September 30, 2022 | 92.08% |
| August 31, 2022 | 92.08% |
| July 31, 2022 | 92.08% |
| June 30, 2022 | 92.08% |
| May 31, 2022 | 92.08% |
| April 30, 2022 | 92.08% |
| March 31, 2022 | 92.08% |
| February 28, 2022 | 92.08% |
| January 31, 2022 | 92.08% |
| December 31, 2021 | 92.08% |
| November 30, 2021 | 92.08% |
| October 31, 2021 | 92.08% |
| September 30, 2021 | 92.08% |
| August 31, 2021 | 92.08% |
| July 31, 2021 | 92.08% |
| June 30, 2021 | 92.08% |
| May 31, 2021 | 92.08% |
| April 30, 2021 | 92.08% |
| March 31, 2021 | 92.08% |
| February 28, 2021 | 92.08% |
| January 31, 2021 | 92.08% |
| December 31, 2020 | 92.08% |
| November 30, 2020 | 92.08% |
| October 31, 2020 | 92.08% |
| September 30, 2020 | 92.08% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
92.08%
Minimum
Nov 2019
92.08%
Maximum
Nov 2019
92.08%
Average
92.08%
Median
Nov 2019
Max Drawdown (5Y) Benchmarks
| Eli Lilly and Co | 22.48% |
| Regeneron Pharmaceuticals Inc | 47.49% |
| Ligand Pharmaceuticals Inc | 76.91% |
| Agios Pharmaceuticals Inc | 82.86% |
| ADMA Biologics Inc | 84.77% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -9.732 |
| Beta (5Y) | -0.2446 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 62.37% |
| Historical Sharpe Ratio (5Y) | -0.2067 |
| Historical Sortino (5Y) | -0.5186 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 19.23% |